[{"address1": "Rue Edouard Belin 12", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 10 22 23 55", "website": "https://www.nyxoah.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Taub MBA", "age": 76, "title": "Co-Founder & Chairman", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 138325, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Olivier  Taelman", "age": 51, "title": "CEO & Executive Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 684058, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Loic  Moreau", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 343597, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruno  Onkelinx", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mikaela  Kirkwood", "title": "Corporate Communication & Investor Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. An  Moonen", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Remi  Renard", "title": "Vice President of Market & Market Access", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inge  Vanwittenbergh", "title": "Global Human Resource Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. DeMartino", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeyakumar  Subbaroyan", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 13.56, "open": 13.51, "dayLow": 13.275, "dayHigh": 13.82, "regularMarketPreviousClose": 13.56, "regularMarketOpen": 13.51, "regularMarketDayLow": 13.275, "regularMarketDayHigh": 13.82, "beta": 0.487, "forwardPE": -7.188172, "volume": 81088, "regularMarketVolume": 81088, "averageVolume": 62355, "averageVolume10days": 75370, "averageDailyVolume10Day": 75370, "bid": 13.09, "ask": 13.57, "bidSize": 100, "askSize": 100, "marketCap": 417438144, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 20.0, "priceToSalesTrailing12Months": 96.006935, "fiftyDayAverage": 12.56326, "twoHundredDayAverage": 8.146975, "currency": "USD", "enterpriseValue": 339228832, "floatShares": 11285320, "sharesOutstanding": 28682600, "sharesShort": 175683, "sharesShortPriorMonth": 188184, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.0061000003, "heldPercentInsiders": 0.45186, "heldPercentInstitutions": 0.23833999, "shortRatio": 2.74, "shortPercentOfFloat": 0.01, "impliedSharesOutstanding": 31222000, "bookValue": 3.41, "priceToBook": 3.920821, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -43212000, "trailingEps": -1.68, "forwardEps": -1.86, "enterpriseToRevenue": 78.02, "enterpriseToEbitda": -7.6, "52WeekChange": 0.8265027, "SandP52WeekChange": 0.29191303, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NYXH", "underlyingSymbol": "NYXH", "shortName": "Nyxoah SA", "longName": "Nyxoah S.A.", "firstTradeDateEpochUtc": 1619616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "067cdc20-d2e6-3884-af4a-437fe8703370", "messageBoardId": "finmb_264235912", "gmtOffSetMilliseconds": -14400000, "currentPrice": 13.37, "targetHighPrice": 26.86, "targetLowPrice": 17.91, "targetMeanPrice": 21.29, "targetMedianPrice": 19.9, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 57748000, "totalCashPerShare": 2.009, "ebitda": -44638000, "totalDebt": 12704000, "quickRatio": 4.412, "currentRatio": 4.732, "totalRevenue": 4348000, "debtToEquity": 12.96, "revenuePerShare": 0.155, "returnOnAssets": -0.20863001, "returnOnEquity": -0.39581, "revenueGrowth": 0.396, "grossMargins": 0.61914, "operatingMargins": -5.9413395, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-03-27"}]